Armstrong Advisory Group
COGT icon

Armstrong Advisory Group’s Cogent Biosciences COGT Stock Holding History

Armstrong Advisory Group’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.71K Hold
272
– – ﹤0.01% 726
2026
Q2 		$10.5K Hold
272
– – ﹤0.01% 702
2026
Q1 		$10.5K Buy
+272
New +$10K ﹤0.01% 680

Other funds holding COGT

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Harbor Investment Advisory
Harbor Investment Advisory Lutherville, Maryland $1.47B AUM 24.2% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Essential Partners
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
Versant Capital Management
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Armstrong Advisory Group's COGT Position: Q3 2026 in Review

Armstrong Advisory Group held its Cogent Biosciences (COGT) position steady in Q3 2026 at 272 shares worth $8.71K. The position accounts for ﹤0.01% of the portfolio, ranked #726.

Armstrong Advisory Group first reported a position in COGT in Q1 2026 and has held it in 3 quarters since. The position peaked at $10.5K in Q2 2026. 21 funds tracked by Wall St. Rank hold COGT as of Q3 2026.

  • Armstrong Advisory Group held 272 shares of Cogent Biosciences worth $8.71K as of Q3 2026.
  • Armstrong Advisory Group left its Cogent Biosciences share count unchanged in Q3 2026.
  • Cogent Biosciences made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q3 2026, its #726 holding.
  • Armstrong Advisory Group first reported a position in Cogent Biosciences in Q1 2026 and has held it in 3 quarters since.
  • Armstrong Advisory Group's Cogent Biosciences position peaked at $10.5K in Q2 2026.
  • 21 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2026.

Based on Armstrong Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.